Similar articles

• [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].

  Kretschmer L, Helmbold P, Emmert S, Marsch WC. Kretschmer L, et al. Hautarzt. 2002 Aug;53(8):536-41. doi: 10.1007/s00105-002-0398-9. Hautarzt. 2002. PMID: 12221468 Clinical Trial. German.
• Approaches to regional nodes in patients with melanoma.

  Deperalta DK, Hoang MP, Tanabe KK. Deperalta DK, et al. J Clin Oncol. 2014 Mar 20;32(9):881-5. doi: 10.1200/JCO.2013.52.3571. Epub 2014 Feb 10. J Clin Oncol. 2014. PMID: 24516017 No abstract available.
• [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity].

  Huber R, Krüger I, Stützer H. Huber R, et al. Langenbecks Arch Chir Suppl Kongressbd. 1996;113:118-21. Langenbecks Arch Chir Suppl Kongressbd. 1996. PMID: 9101808 German.
• Adjuvant therapy in melanoma.

  Mohr P, Weichenthal M, Hauschild A. Mohr P, et al. Onkologie. 2003 Jun;26(3):227-33. doi: 10.1159/000071617. Onkologie. 2003. PMID: 12845206 Review.
• Cutaneous melanoma: interferon alpha adjuvant therapy for patients at high risk for recurrent disease.

  Lens M. Lens M. Dermatol Ther. 2006 Jan-Feb;19(1):9-18. doi: 10.1111/j.1529-8019.2005.00051.x. Dermatol Ther. 2006. PMID: 16405565 Review.